US bourses drifted higher last Friday (4 June), given easing worries about the Fed's liquidity tap closing under May's non-farm payroll miss, said Matthew Kwok, Vice President of Business Department at Zhenro. Techs were in shape, shoring up the three key US indices at close.
Being meager, HSI had been struggling at the 29,000 level recently with bluechips in mixed bags. The HSI constituent change post-QoQ review took effect, ramping up market transactions. The brisk foreign sentiment had alleviated pressure on market refreshment. Investors were mindful of FOMC meeting results, while Kwok projected HSI to keep moving sideways between 28,500 and 29,500.
On another note, China's NMPA asked third-party drug network sales platforms like BABA-SW (09988.HK), JD-SW (09618.HK) and TENCENT (00700.HK) to strictly fulfill their responsibilities as platform entities. Despite near-term business impact from tougher regulation, Kwok expected China to promote a healthy and orderly sector development in long run, thus staying optimistic about the prospects of sector leaders like ALI HEALTH (00241.HK) and JD HEALTH (06618.HK).
(The author is the licensee of SFC, who does not hold the above shares)
Being meager, HSI had been struggling at the 29,000 level recently with bluechips in mixed bags. The HSI constituent change post-QoQ review took effect, ramping up market transactions. The brisk foreign sentiment had alleviated pressure on market refreshment. Investors were mindful of FOMC meeting results, while Kwok projected HSI to keep moving sideways between 28,500 and 29,500.
On another note, China's NMPA asked third-party drug network sales platforms like BABA-SW (09988.HK), JD-SW (09618.HK) and TENCENT (00700.HK) to strictly fulfill their responsibilities as platform entities. Despite near-term business impact from tougher regulation, Kwok expected China to promote a healthy and orderly sector development in long run, thus staying optimistic about the prospects of sector leaders like ALI HEALTH (00241.HK) and JD HEALTH (06618.HK).
(The author is the licensee of SFC, who does not hold the above shares)